{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treating the Patient With Nonalcoholic Fatty Liver Disease

Activity Steps

Purpose of Activity

To present an overview of NAFLD with updated treatment recommendations.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Define NAFLD, its risk factors, and pathophysiology.
  2. Explain the diagnostic process and findings.
  3. Identify current treatment recommendations.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 1.0 APH
  • DC - BON 2.0 CH
  • KY-BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours







Test Code: NP1115B
Published: Nov 2015
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Authors: Amanda Chaney, MSN, ARNP, FNP-BC
Specialties: Gastroenterology